Morgan Stanley Molecular Partners Ag Call Options Transaction History
Morgan Stanley
- $1.59 Trillion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MOLN
# of Institutions
7Shares Held
3.58MCall Options Held
0Put Options Held
0-
Suvretta Capital Management, LLC New York, NY2.22MShares$9.37 Million0.25% of portfolio
-
Bvf Inc San Francisco, CA1.35MShares$5.71 Million0.28% of portfolio
-
Ubs Group Ag5.34KShares$22,5300.0% of portfolio
-
Bank Of America Corp Charlotte, NC157Shares$6620.0% of portfolio
-
Ever Source Wealth Advisors, LLC155Shares$6540.0% of portfolio
About MOLECULAR PARTNERS AG
- Ticker MOLN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,514,000
- Market Cap $137M
- Description
- Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, ...